Ayhan Bilgici

Ayhan Bilgici

Auto-generated profile, based on publicly available information

Ayhan Bilgici

ONDOKUZ MAYIS ÜNİVERSİTESİ, TIP FAKÜLTESİ

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2019 in Advances in Rheumatology
Verified
Journal Article
Open access
PDF file
YUYasemin Ulus
Yasemin Ulus
YAYesim Akyol
Yesim Akyol
ABAyhan Bilgici
Ayhan Bilgici
OKOmer Kuru
Omer Kuru
Background: Coexisting fibromyalgia (FM) to psoriatic arthritis (PsA) has been identified and it has been associated with more severe symptoms, impaired function, and greater disability. It was aimed to explore the effect of the presence of FM on fatigue in patients with PsA comparing with controls.Methods: Fifty patients with PsA and 34 sex-age matched controls were enrolled. In patients; pain was assessed by Visual Analogue Scale, disease activity by DAS-28, enthesitis by The Leeds Enthesitis Index. Fatigue level of all participants was evaluated by Multidimensional Assessment of Fatigue. In all participants, FM was determined according to 2010 American College of Rheumatology criteria.Results: Seventeen patients with PsA (34%) and 4 controls (11.8%) were diagnosed with FM and all of them were women. There was significant difference between the patients and controls in terms of presence of FM (p < 0.05). Patients’ fatigue scores were significantly higher than controls’ (p = 0.001). There were significant differences between the PsA patients with and without FM with regard to gender, enthesitis, DAS-28 and pain scores (p < 0.05); fatigue scores (p < 0.001). The significant effect of the presence of FM on fatigue was found by univariate analysis of variance in patients (p < 0.001).Conclusion: It was observed that FM presence and fatigue were more common in PsA patients than controls and comorbid FM had significant effect on fatigue in these patients. Physicians should be aware of the possibility of concomitant FM in patients with PsA.

1 April 2020 in Turkish Journal of Osteoporosis
Verified
Journal Article
Closed access
YAYeşim Akyol
Yeşim Akyol
YUYasemin Ulus
Yasemin Ulus
ABAyhan Bilgici
Ayhan Bilgici
ÖKÖmer Kuru
Ömer Kuru

1 August 2021 in Turkish Journal of Osteoporosis
Verified
Journal Article
Closed access
SMSALİM MISIRCI
SALİM MISIRCI
YAYeşim Akyol
Yeşim Akyol
YUYasemin Ulus
Yasemin Ulus
ACAhmet Kıvanç Cengiz
Ahmet Kıvanç Cengiz
ABAyhan Bilgici
Ayhan Bilgici

1 June 2017 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
AYA Yesim
A Yesim
YUY Ulus
Y Ulus
TBT Berna
T Berna
LTL Tomak
L Tomak
YZY Zahiroglu
Y Zahiroglu
OKO Kuru
O Kuru
Background Rheumatoid arthritis (RA) is a chronic disease that affects the bone and joints. Patients with RA migth be considered to be at increased risk of falls and FOF for a variety of reasons, including the presence of muscle weakness and stiff or painful joints of the lower extremities resulting in impaired physical activity, mobility, balance, and postural stability (1,2). Objectives The aim of the present study was to compare fall history and fear of falling (FOF) in patients with RA with healthy controls, and to investigate their relationships between the demographic features, severity of pain, disability, disease activity, walking velocity, balance and emotional status in patients with RA. Methods One hundred-twenty patients with RA and 60 healthy volunteers were included in the study. Their fall history (yes, no) and the number of falls within the last year were questioned. FOF by presence of FOF (yes/no) and by Falls Efficacy Scale-International-I (FES-I), walking time by 10 Meter Walk Test (10MWT), balance by One-Leg Stand Test (OLST) and Berg Balance Scale (BBS), emotional status by Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI) were performed in both groups. Pain severity and patient global assessment (PGA) by Visual Analogue Scale (VAS), disability by the Health Assessment Questionnaire (HAQ), disease activity by Disease Activity Score-28 (DAS-28) were evaluated in patients with RA. Results There was no statistically difference between the RA patients and controls in terms of presence of fall history while presence of FOF and FES-I scores were significantly high in patients. PGA, 10MWT, pain VAS, HAQ, FES-I, BAI and BDI scores were significantly high, BBS score and OLST were significantly low fallers when compared to the non-fallers in the patients (p<0.05). In the patient group, FES-I score was significantly correlated with pain VAS, PGA, DAS-28, HAQ, BAI, BDI, 10MWT positively, and BBS, OLST negatively (p<0.05). In regression analysis; the number of falls, HAQ, BBS and BDI scores were detected to be the apparent independent risk factors affecting variations in FES-I scores (p<0.001). Conclusions According to the results of our study, ambulatory patients with RA have increased FOF, disturbed balance, increased walking time and impaired emotional status compared with controls. On the other hand; walking time, pain severity, disability, scores of emotional status and PGA were higher, while the balance scores were lower in the RA patients with fallers. There were relationships between FOF and increased pain, high disease activity and anxiety level, impaired PGA, increased walking time but the most important factors associated with FOF were impaired balance, increased disability and depression, and number of falls in RA patients. Strategies for preventing falls, maintaining balance, improving emotional status and againts FOF are of the utmost importance in patients with RA. References Armstrong C, Swarbrick CM, Pye SR, O'Neill TW. Occurrence and risk factors for falls in rheumatoid arthritis. Ann Rheum Dis.2005;64:1602–4. Jamison M, Neuberger GB, Miller PA. Correlates of falls and fear of falling among adults with rheumatoid arthritis. Arthritis Rheum. 2003;49:673–80. References Disclosure of Interest None declared

1 January 2022 in Journal of Experimental and Clinical Medicine
Verified
Journal Article
Closed access
SKSertaç Ketenci̇
Sertaç Ketenci̇
BUBora Uzuner
Bora Uzuner
ABAyhan Bi̇lgi̇ci̇
Ayhan Bi̇lgi̇ci̇
Psoriatic arthritis (PsA) is a chronic inflammatory multisystemic disease. Limitations due to skin and joint involvement of the patients; can lead to negativie suffix in emotional state, social and physical activities. The aim of this study is to investigate the effects of parameters such as skin joint involvement and disease severity on factors such as fatigue, quality of life, depression, etc. in psoriasis and PsA patients. Thirty-four psoriasis and 48 PsA patients matched with each other in terms of age, sex, and other factors were included in the study. Disease severity was measured by Psoriasis Area Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Disease Activity in Psoriatic Arthritis (DAPSA) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) scores. In order to determine the depression status, quality of life and fatigue levels of the patients, respectively; Beck Depression Inventory (BDI), Health Assessment Questionnaire (HAQ) and Functional Assessment of Chronic Illness Therapy - fatigue scale (FACIT) scores were used. SPSS 17 for statistical evaluation (SPSS Inc. Released 2007. SPSS for Windows, Version 17.0. Chicago, SPSS Inc.) software package was used for analyses. Written informed consent was obtained from all patients who were enrolled to the study. PsA patients were found to have worse quality of life scores than psoriasis patients who were similar in terms of age, gender and other demographic characteristics. (0.22±0.36-0-0.48±0.52 p=0.017 respectively). There was a strong correlation between DAPSA scores and HAQ scores of the cases in the PsA group (r:0 ,615 p<0.05). Likewise, disease activity measured by DAPSA was found to have moderate correlation with FACIT score, and weak but statistically significant correlation with BDI score. (r: -0.578 p<0.05 and r:0.346 p<0.001, respectively). No correlation was found between NAPSI-PASI scores and HAQ, BDI - FACIT scores in both the psoriasis and PsA groups. Both psoriasis and PsA affect the quality of life, and our findings suggest that this effect is more pronounced in PsA patients. Our study supports that; the disease severity in PsA patients is related to depression, bad quality of life and fatigue level.

31 December 2025 in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
Verified
Journal Article
Closed access
BUBora Uzuner
Bora Uzuner
SKSertaç Ketenci
Sertaç Ketenci
ESEnder Salbaş
Ender Salbaş
ABAyhan Bilgici
Ayhan Bilgici
Objective: Patients with rheumatoid arthritis (RA) suffer from high burdens of fatigue and poor sleep quality which persist even when joint inflammation is controlled. We aimed to retrospectively evaluate the 3-month impact of initiating anti-TNF therapy initiation on fatigue sleep quality and functional status in patients with active RA. Methods: We conducted a 3-month single-center retrospective cohort study reviewing the records of 39 patients with active RA (Disease Activity Score 28 [DAS28] > 5.1) despite stable csDMARDs. A matched group of 36 healthy controls was used for baseline comparisons. Patients had initiated adalimumab, etanercept, or infliximab. Assessments had been performed at baseline and 3 months using the DAS28 (disease activity), Health Assessment Questionnaire (HAQ), Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF), Pittsburgh Sleep Quality Index (PSQI), and Beck Depression Inventory (BDI). 31 patients had completed the 3-month follow-up and had complete data for analysis. Results: At 3 months, patients showed significant clinical improvement. Mean DAS28 decreased from 5.5 ± 1.2 to 3.3 ± 1.6 (p < 0.001) and 39% (12/31) achieved remission. Significant improvements were seen in patient-reported outcomes. The mean MFSI-SF total fatigue score decreased from 27.6 to 10.4 (p < 0.001) and the mean global PSQI score improved from 9.5 to 7.0 (p < 0.001). Functional status (HAQ) and depressive symptoms (BDI) also improved significantly (both p < 0.001). At baseline, fatigue strongly correlated with poor sleep (r=0.626), depression (r=0.674), and HAQ (r=0.656). Improvement in fatigue correlated moderately with improvement in depression (Δ-BDI r=0.571). Conclusion: Anti-TNF therapy provides rapid and significant improvements not only in clinical disease activity but also in the key patient-reported burdens of fatigue, sleep quality, and depression within three months of initiation. Keywords: rheumatoid arthritis, anti-TNF therapy, fatigue, sleep quality,